hotspot -WSS

hotspot

author：focus 2025-09-27 22:50:07 - browse：165

Colorful illustration of scientists using computers and Artificial Intelligence technology to visualize proteins for drug development – biotech coverage from STAT — Mike Reddy for STAT

David Reese calls it a “hinge moment” — the turning point when biotech and big tech merge to attack human disease with artificial intelligence.

At Amgen, where he’s led drug research and development since 2018, Reese said this moment has finally arrived. The proof lies not only in organizational changes, such as his recent appointment as the company’s first chief technology officer, but also in Amgen’s broader push to embed AI into every aspect of the drug discovery process.

“We’re now seeing 10-fold improvements in these (AI) models every six months,” said Reese, a medical oncologist by training. He added that the quickening pace of advancement means investing in the technology is no longer optional: “It’s something we must do to have a practical, pragmatic impact on drug discovery.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： 5 takeaways from STAT's examination of Zynex Medical

knowledge

WSS

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

NIH tests clinical research in primary care with $30 million program

Lilly's Alzheimer's drug donanemab backed by FDA advisers

Medical device trials still don't enroll enough women, study finds

ALS patient reclaims some autonomy thanks to wearable 'robot'

Moderna says combo Covid

hotspot

hotspot

focus

After affirmative action ruling, medical educators look to 'holistic review'

How climate

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Cigna wins case to block Amy Bricker's move to CVS

Hollywood unions extend contract negotiations for actors

STAT Readout Newsletter: Today's biggest biotech updates

Continuity nursing helped my family in our darkest PICU moments

CEOs share strategies for surviving biotech slump

How to save PrEP access — and even expand it

California wildfire smoke linked to 52,000 early deaths, study says

knowledge

CEOs share strategies for surviving biotech slump

5 takeaways from STAT's examination of Zynex Medical

Lawmakers consider Medicare pay reforms for doctors

UnitedHealth’s board chair also owns a personal investment firm

New report analyzes digital physical therapy solutions' effectiveness

Lilly's Alzheimer's drug donanemab backed by FDA advisers

knowledge

explore

focus

focus